| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 91.840 | 212.554 | 168.914 | 259.435 | 229.207 | 49.250 | 106.953 | 182.315 | 225.894 | 925.935 |
| Total Income - EUR | 94.161 | 212.941 | 173.198 | 261.204 | 232.203 | 50.376 | 107.087 | 182.402 | 226.289 | 927.191 |
| Total Expenses - EUR | 17.496 | 25.262 | 26.388 | 38.992 | 31.080 | 35.860 | 45.230 | 53.290 | 54.839 | 246.295 |
| Gross Profit/Loss - EUR | 76.665 | 187.680 | 146.810 | 222.212 | 201.123 | 14.516 | 61.857 | 129.112 | 171.450 | 680.896 |
| Net Profit/Loss - EUR | 73.841 | 184.100 | 145.079 | 219.601 | 198.999 | 14.023 | 60.809 | 127.325 | 164.797 | 653.673 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 |
Check the financial reports for the company - Sal Med Srl
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.164 | 2.313 | 28.846 | 64.206 | 56.578 | 41.967 | 29.801 | 18.156 | 15.006 | 52.446 |
| Current Assets | 60.757 | 176.023 | 113.361 | 145.730 | 133.980 | 17.615 | 73.192 | 171.485 | 191.598 | 628.250 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 513 | 512 | 0 | 0 |
| Receivables | 32.974 | 5.427 | 32.757 | 13.515 | 10.780 | 14.766 | 61.037 | 118.602 | 166.688 | 588.928 |
| Cash | 27.783 | 50.351 | 12.738 | 14.874 | 58.572 | 2.848 | 11.641 | 11.938 | 24.910 | 39.322 |
| Shareholders Funds | 68.612 | 184.153 | 145.130 | 219.652 | 199.049 | 14.072 | 60.858 | 127.373 | 164.846 | 653.913 |
| Social Capital | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 | 200 |
| Debts | 8.082 | 3.882 | 5.095 | 3.119 | 3.080 | 55.978 | 49.223 | 67.170 | 46.035 | 47.197 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 1 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sal Med Srl